Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
ARDS
COVID-19
Chest CT
Invasive ventilation
Pneumonia
SARS-CoV-2
TLCO
Vital capacity
Journal
Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
29
01
2021
revised:
20
04
2021
accepted:
21
04
2021
pubmed:
22
5
2021
medline:
15
7
2021
entrez:
21
5
2021
Statut:
ppublish
Résumé
Lung function in survivors of SARS-Co-V2 pneumonia is poorly known, but concern over the possibility of sequelae exists. Retrospective study on survivors with confirmed infection and pneumonia on chest-CT. Correlations between PFT and residual radiologic anomalies at three months taking into account initial clinical and radiological severity and steroid use during acute phase. 137 patients (69 men, median age 59 (Q1 50; Q3 68), BMI 27.5 kg/m The majority of patients have altered PFT at three months, even in patients with mild initial disease, with significantly lower function in patients with residual CT lesions. Steroids do not seem to modify functional and radiological recovery. Long-term follow-up is needed.
Identifiants
pubmed: 34020126
pii: S0954-6111(21)00141-4
doi: 10.1016/j.rmed.2021.106435
pmc: PMC8123365
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106435Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
Infection. 2020 Aug;48(4):543-551
pubmed: 32342479
Crit Care Resusc. 2006 Dec;8(4):302-8
pubmed: 17227266
Thorax. 2005 May;60(5):401-9
pubmed: 15860716
EClinicalMedicine. 2020 Aug;25:100463
pubmed: 32838236
Eur Radiol. 2020 Sep;30(9):4903-4909
pubmed: 32314058
Thorax. 2020 Dec;75(12):1116-1118
pubmed: 32839288
Eur Respir Rev. 2020 Oct 5;29(157):
pubmed: 33020069
Crit Care Med. 2020 Nov;48(11):e1079-e1086
pubmed: 32826432
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32430410
Eur Respir J Suppl. 1993 Mar;16:41-52
pubmed: 8499053
Eur Respir J. 2021 Apr 29;57(4):
pubmed: 33419891
Intensive Care Med. 2020 Jun;46(6):1124-1126
pubmed: 32328726
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
Eur Respir J. 2020 Jul 23;56(1):
pubmed: 32703822
Thorax. 2020 Nov;75(11):1009-1016
pubmed: 32839287
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32381497
Eur Respir J. 2020 Aug 6;56(2):
pubmed: 32554533
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Eur Respir J Suppl. 1993 Mar;16:5-40
pubmed: 8499054
Thorax. 2021 Apr;76(4):402-404
pubmed: 33273023